The correlation analysis of primary liver cancer with Type 2 diabetes

Indian Journal of Cancer

Volumn 52, Issue 7, 2015, Pages e148-e152

  Su, Q ^a   Sun, F ^a   Li, J ^a   Zhang, H ^a   Wang, M ^a   Zhou, H ^a   Qiao, L ^a  

^a Yishui Central Hospital   (China)

Author keywords

Correlation; incidence; primary liver cancer; Type 2 diabetes

Indexed keywords

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHI SQUARE TEST; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SEX RATIO; STATISTICAL ANALYSIS; BLOOD; CHINA; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; INCIDENCE; LIVER NEOPLASMS; METABOLISM;

GLUCOSE BLOOD LEVEL;

AGED; BLOOD GLUCOSE; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84987924149     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.186557     Document Type: Article

References (18)

1. Zeng G, Rui W, Grouse L. Diabetes mellitus increases postoperative mortality in non-small cell lung cancer. Thorac Cancer 2014;5:111.
2. Washington I, Chino JP, Marks LB, D'Amico TA, Berry MF, Ready NE, et al. Diabetes mellitus: A signifcant co-morbidity in the setting of lung cancer? Thoracic Cancer 2013;4:123-30.
3. Chen JY, Chiou WK, Chou WY, Lin JD. The impact of type 2 diabetes mellitus on mortality in hospitalized female cancer patients in Taiwan. Asia Pac J Clin Oncol 2016;12:e75-81.
4. Gao S, Yang W, Gao J. Meta analysis of diabetes and primary liver cancer cohort study. Zhonghua Yi Xue Za Zhi 2010;44:711-6.
5. Srimuninnimit V, Sriuranpong V, Suwanvecho S. Effcacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study. Asia Pac J Clin Oncol 2014;10:255-60.
6. Ford ES, Li C, Little RR, Mokdad AH. Trends in A1C concentrations among U.S. adults with diagnosed diabetes from 1999 to 2004. Diabetes Care 2008;31:102-4.
7. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-101.
8. Zhang S, Chen W, Lei Z. China tumor registry in 2004 malignant tumor incidence data analysis. Zhong Guo Zhong Liu 2008;11:909-12.
9. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: A follow-up study in Taiwan. Gastroenterology 2008;135:111-21.
10. Bi Y, Lu J, Wang W, Mu Y, Zhao J, Liu C, et al. Cohort profle: Risk evaluation of cancers in Chinese diabetic individuals: A longitudinal (REACTION) study. J Diabetes 2014;6:147-57.
11. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: A population based case control study. Gut 2005;54:533-9.
12. Wotton CJ, Yeates DG, Goldacre MJ. Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: Record linkage studies. Diabetologia 2011;54:527-34.
13. Wang CS, Yao WJ, Chang TT, Wang ST, Chou P. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol Biomarkers Prev 2009;18:2054-60.
14. Hu R, Pan J, Lu F, He Q, Cao N,Wang Y, et al. The correlation study of sugar metabolism and malignant tumor risk research. Zhonghua Liu Xing Bing Xue Za Zhi 2014;35:759-63.
15. Donadon V, Balbi M, Ghersetti M, Grazioli S, Perciaccante A, Della Valentina G, et al. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease. World J Gastroenterol 2009;15:2506-11.
16. Gallagher EJ, LeRoith D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab 2010;21:610-8.
17. Liu H, Ma Q, Li J. High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells. Mol Cell Biochem 2011;347:95-101.
18. Yamasaki K, Hayashi Y, Okamoto S, Osanai M, Lee GH. Insulin-independent promotion of chemically induced hepatocellular tumor development in genetically diabetic mice. Cancer Sci 2010;101:65-72.